HLN: Pangali EV/EBITDA haleon.com

Haleon plc faces a debt burden following its spin-off from GSK and legal claims regarding Zantac, risking market share due to cheap generics. On GURU.Markets, the business's EV/EBITDA multiple helps identify a fundamental bottom, where 12.46 records fresh values. Efficient wholesale delivery to pharmacies reduces costs, while internal brand portfolio optimization replaces active asset acquisitions.

For Haleon plc, which is focused on reducing debt load and internal optimization, this multiple serves as a tool for assessing market value relative to operating profit. The metric correlates enterprise value (EV) with EBITDA, excluding the impact of taxes and depreciation to reveal the actual efficiency of assets. By analyzing the historical EV/EBITDA trend of the company on the GURU.Markets platform, an investor can track the business valuation dynamics. The current value of 12.46 makes it possible to determine whether the asset is overvalued or remains in a zone of fundamental undervaluation.